Community/Retail

The existing EUA was also amended to reduce the time for booster dose administration from a minimum of 6 months to at least 5 months following completion of the primary COVID-19 vaccine series.

Pharmacists can play a key role in providing education and guidance to patients with glaucoma.

Witch hazel is used for conditions such as diarrhea, mucus colitis, and various other skin irritations.

The FDA has granted emergency use authorization for a COVID-19 at-home test (Roche) and a rapid COVID-19 antigen self-test (Clinitest; Siemens Healthineers).

Individuals receiving the therapy had an 87% reduction in risk for the composite primary endpoint of virus-related hospitalization or all-cause death by day 28.

The therapeutic is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022.

When assessing treatments for flu and cold symptoms, it is important for the pharmacist to consider not only the patient’s current medication regimen, but also other OTCs and disease states.

The research team compared the monthly average blood pressures between 2018 and 2019 with blood pressure measures from January through March 2019 to January through March 2020.

The findings showed that people with HIV were 68% more likely to develop heart failure than people who did not have HIV.

Immune B cells secrete immunoglobin A antibodies that work on mucosal surfaces in the nose, stomach, and lungs.

Curoxen helps to prevent infection and treats cuts, scrapes, blisters, and burns.

Advair Diskus is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease.

Symptoms of Gaucher disease include abdominal complaints, skeletal abnormalities, and blood disorders.

Avapro (Irbesartan) is indicated for the treatment of hypertension and used to lower blood pressure.

OTC case studies for December 2021.

The FDA approves anifrolumab-fnia injection (Saphnelo; AstraZeneca) for the treatment of adults with moderate to severe system- ic lupus erythematosus (SLE) who are receiving standard therapy.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses her hopes for the future of SHC’s diabetes DRIVE program and its adoption within health systems.

Gallstones range in size from as small as a grain of sand to as large as a golf ball.

Cabenuva (Cabotegravir-rilpivirine) is a 2-drug co-packaged product indicated as a complete regimen for the treatment of HIV-1 infection in adults.

Glycerin Suppositories are indicated for acute and temporary episodes of constipation.

Promoting a positive organizational culture is an essential requirement for the effective management of a community pharmacy.

This month's products features baby probiotic, liquid-filled aspirin capsules, and Alocane maximum strength first aid antiseptic spray.

Study predicts the future of antibody testing may move toward technologically advanced platforms that can test for multiple antibody types in a single blood sample.

Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health at the National Institutes of Health, provides some closing thoughts on sex and gender in health care.

How would you respond to these patients' questions?

Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses the problems with approaching public health issues, such as mental health and substance use disorders, with an industrialized approach to problem solving.

Sarah Temkin, MD, of the Office of Research on Women’s Health at the National Institutes of Health, discusses some key points for pharmacists on the impact of biological and sociological variables on treatment outcomes.

Brought to You by The Sassy Pharmacist

Tom Hanzel, PharmD, MBA, discussed how vaccine mandates impact staffing shortages in long-term care facilities.

Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses whether the adoption and acknowledgement of psychedelic medicine in health care systems looks likely for the future.